Lipid carriers: A versatile delivery vehicle for proteins and peptides

Yakugaku Zasshi

Volumn 128, Issue 2, 2008, Pages 269-280

  Rawat, Manju ^a   Singh, Deependra ^a   Saraf, S ^a   Saraf, Swarnlata ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Delivery system; Lipid; Peptide; Protein

Indexed keywords

DRUG CARRIER; LIPID; LIPID EMULSION; LIPOSOME; PEPTIDE; PROTEIN; SOLID LIPID NANOPARTICLE;

BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; IMPLANT; LIPOSOMAL DELIVERY; MICROBUBBLE; MICROEMULSION; MICROTUBULE; REVIEW; SUSPENSION;

BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; LIPIDS; LIPOSOMES; MICROBUBBLES; MICROTUBULES; NANOPARTICLES; PEPTIDES; PROTEINS;

EID: 39049139244     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.269     Document Type: Review

References (104)

1. Banga A. K., "Therapeutic peptides and proteins-formulation, processing and delivery systems," 2nd ed., CRC press, Taylor and Francis group, Boca Raton, London, 2005.
2. Talukder G.,: 〈http://www.bccresearch.com/bio/BIO009E.asp〉, 7 January 2007.
3. Manning M. C., Patel K., Borchardt R. T. Pharm. Res., 6, 903-918 (1989).
4. Tomlinson E., Adv. Drug Del. Rev., 1, 87-198 (1987).
5. Khan M. Z. I., Tucker I. G., Opdebeeck J. P., Int. J. Pharm., 76, 161-170 (1991).
6. Wang P. Y., Int. J. Pharm., 54, 223-230 (1989).
7. Walduck A. K., Opdebeeck J. P., Benson H. E., Prankerd R., J. Control Rel., 51, 269-280 (1998).
8. Reithmeier H., Herrmann J., Goepferich A., Int. J. Pharm., 218, 133-143 (2001).
9. Reithmeier H., Herrmann J., Goepferich A., J. Control Rel., 73, 339-350 (2001).
10. Lukowski G., Pflegel P., Pharmazie, 52, 642-643 (1997).
11. Allen T. M., Drugs, 54 (suppl) 4, 8-14 (1997).
12. Lasic D. D., Vallner J. J., Working P. K., Curr. Opin. Mol. Ther. 1, 177-185 (1999).
13. Khanna C., Hasz D. E., Klausner J. S., Anderson P. M., Clin. Cancer Res., 2, 721-734 (1996).
14. Collins D., Cha Y. S., Biochemistry, 33, 4521-4526 (1994).
15. Hlodan R., Pain R. H., FEBS Lett. 343, 256-260 (1994).
16. Berger J. T., Otter W. D., Dullens H. F. J., Kerkvliet C. T. M., Crommelin D. J. A., Pharm. Res., 10, 1715 (1993).
17. Storm G., Koppenhagen F., Heeremans A., Vingerhoeds M., Woodle M. C., Crommelin D. J. A., J. Control Rel., 36, 19-24 (1995).
18. Ye Q., Asherman J., Stevenson M., Brownson E., Katre N. V., J. Control Rel., 64, 155-166 (2000).
19. Katre N. V., Asherman J., Schaefer H., Hora M., J. Pharm. Sci., 87, 1341-1346 (1998).
20. Langston M. V., Ramprasad M. P., Kararli T. T., Galluppi G. R., Katre N. V., J. Control. Rel., 89, 87-99 (2003).
21. Papahadjopoulos D., Vail W. J., Jacobson K., Poste G., Biochim. Biophys. Acta 394, 483-491 (1975).
22. Delmarre D., Lu R., Tatton N., Krause-Elsmore S., Gould-Fogerite S., Mannino R. J. Drug Deliv. Technol., 4, 64-69(2004).
23. Gould-Fogerite S., Mannino R. J., In Methods in Molecular Medicine, Vol. 42, Vaccine Adjuvants: Preparation Methods and Research Protocols, ed. by O'Hagan, D. T., Humana Press, Totowa, NJ, 2000, p. 179.
24. Wolfgang M., Karsten M., Adv. Drug Del. Rev., 47, 165-196 (2001).
25. Muller R. N., Schwarz C., Metinert W., Lucks J. S., Proc. Int. Symp. Control Release Bioact Mater, 20, 480-481 (1993).
26. Gasco M. R., US Patent 5250 236 (1993).
27. Siekmann B., Westesen K., Eur. J. Pharm. Biopharm., 43, 104-109 (1996).
28. Speiser P., European Patent EP 0167825 (1990).
29. Wissing S. A., Kayser O., Muller R. H., Adv. Drug Del. Rev. 56, 1257-1272 (2004).
30. Sanna V., Kirschvink N., Gustin P., Gavini E., Roland I., Delattre L., Evrard B., AAPS Pharm. Sci. Tech., 5, 1-7 (2003).
31. Muller R. H., Dinglet A., Eurocosmetics, 7, 19-26 (1998).
32. Jenning V., Gysler A., Korting M. S., Gohla S. H., Eur. J. Pharm. Biopharm., 49, 211-218 (2000).
33. Muller R. H., Maaben S., Weyhers H., Specht F., Lucks J. S., Int. J. Pharm., 138, 85-94 (1996).
34. Garcia-Fuentes M., Torres D., Alonso M. J., Int. J. Pharm., 296, 122-132 (2005).
35. Ugazio E., Cavalli R., Gasco M. R., Int. J. Pharm., 241 (2), 341-344 (2002).
36. Almeida A. J., Runge S., Mueller R. H., Int. J. Pharm., 149, 255-265 (1997).
37. Carrasquillo K. G., Cordero R. A., Ho S., Franquiz J. M., Griebenow K., Pharmacy and Pharmacology Communications, 4, 563-571 (1998).
38. Nestor J. J., Vickery B. H., Long acting depot injectable formulations for LH-RH analogues. Syntex Inc., Application No. 79-047662, Patent No. US 4, 256, 737 (1979).
39. Mitchell J. W., Monsanto, Co, Application No. 85-870135, Patent No. EP 177478 1993.
40. Goldenberg M. S, Shan D., Beekman A. C., (1999) Amgen Inc., Application No. 99-US30527, Patent No. WO 2000038652 (1985).
41. Klang and Benita, S., (1998) Benita S. (Ed.), Submicron emulsions in drug delivery. Hardwood Academic Publishers, Amsterdam.
42. Rosano H. L., Clausse M., "Microemulsion Systems," 1st ed., Marcel Dekker, New York, 1987.
43. Gerhardt N. I., Dungan, S. R. Biotechnol. Bioeng., 78, 60-72 (2002).
44. Mitra N., Mukherjee L., Bhattacharya P. K., Moulik S. P. Indian J. Biochem. Biophys., 33, 206-212(1996).
45. Mitra N., Mukhopadhyay L., Bhattacharya P. K., Moulik S. P. Indian J. Biochem. Biophys., 31, 115-120 (1994).
46. Gaonkar A. G., Bagwe R. P., Surfactant Science Series, 109, 407-430 (2003).
47. Goklen K. E., Hatton T. A. Sep. Sci. Technol., 22, 831-841 (1987).
48. Cortez, E. V., Felipe, M. D. D., Roberto, I. C. Appl. Biochem. Biotechnol., 91, 753-759 (2001).
49. Jarudilokkul S., Paulsen E., Stuckey D. C., Biotechnol. Bioeng., 69, 618-626 (2000).
50. Pires M. J., AiresBarros M. R., Cabral J. M. S. Biotechnology Progress, 12, 290-301 (1996).
51. Rohloff C. M., Shimek J. W., Dungan S. R. J. Colloid Interface Sci., 261, 514-523 (2003).
52. Tyle P., U. S. Patent, August 15, 1989
53. Cilek A., Celebi N., Tirnaksiz F., Drug Delivery, 13, 19-24 (2006).
54. Tihell A., Lindhom A., Sawe J., Chen G., Norrlind B., Pharm. Toxicol., 76, 115 (1995).
55. Kawakami S., Yamashita F., Hashida M., Adv. Drug Deliv. Rev., 45, 77-88 (2000).
56. Shah N. H., Caryajal M. T., Patel C. I., Infield M. H., Malick V. W., Int. J. Pharm., 106, 15-23 (1994).
57. Nazzal S., Zaghloul A., Khan M. A., Pharm. Tech., 26, 86-98 (2002).
58. Kent J. S., Syntex, U. S. A., Application No. 82-446749, Patent No. US 4, 452, 775 (1982).
59. Wang P. Y. Diabetes, 36, 1068-1072 (1987).
60. Opdebeeck J. P., Tucker I. G., J. Control Rel., 23, 271-279 (1993).
61. Cady S. M., Fishbein R., SanFilippo M., Controlled Release Society, Proceed. Intern. Symp. Control. Rel. Bioact. Mater 25, 350-351 (1988).
62. Cady S. M., Fishbein R., American Cyanamid Co., USA., Application No. 91-661787, Patent No. US 5, 137, 874 (1991).
63. Steber W. D., Fishbein R., Cady S. M., American Cyanamid Company, Application No. 89-078926, Patent No. US 4, 837, 381 (1989).
64. Steber W. D., Cady S. M., Johnson D. F., Haughey T. R., American, Cyanamid Co, Application No. 95-456167, Patent No. US 5, 801, 141 (1995).
65. Goepferich A., Maschke A., Vogelhuber W., Application No. 2002-EP14172, Patent No. WO 2003049719 (2002).
66. Vogelhuber W., Magni E., Mouro M., Spruss T., Guse C., Gazzaniga A., Goepferich A. Pharm. Dev. Technol., 8, 71-79 (2003).
67. Vogelhuber W., Magni E., Gazzaniga A., Goepferich A., Eur. J. Pharm. Biopharm., 55, 133-138 (2003).
68. Koennings S., Garcion E., Faisant N., Menei P., Benoit J. P., Goepferich A., Int. J. Pharm., 314, 145-152 (2006).
69. Ismail F. A., Napaporn J., Hughes J. A., Brazeau G. A. Pharm. Dev. Technol., 5, 391-397 (2000).
70. Jong Y. S., Jacob J. S., Yip K. P., Gardner G., Seitelman E., Whitney M., Montogomery S., Mathowitz E., J. Contr. Rel., 47, 123-134 (1997).
71. Schnur J. M., Science, 262, 1669-1676 (1993).
72. Spector M. S., Selinger J. V., Schnur J. M., J. Am. Chem. Soc., 119, 8533-8539 (1997).
73. Price R., Patchan M., J. Microencap., 8, 301-306 (1991).
74. Thomas B. N., Safinya C. R., Plano R. J., Clark N. A., Science, 267, 1635-1638 (1995).
75. Spargo B. J., Cliff R. O., Rollwagen F. M., Rudolph A. S., Biomaterials 13, 1085-1092 (1992).
76. Spargo B. J., Cliff R. O., Rollwagen F. M., Rudolph A. S., J. Microencapsulation, 12, 247-254 (1995).
77. Meilander N. J., Yu X., Ziats N. P., Bellamkonda R. V., 71, 141-152 (2001).
78. Panchal S. C., Meilander N. J., Bellamkonda R. V., Ziats N. P., Soc. Biomater. 28th Ann. Mtg. Trans., 2002 25, p. 504.
79. Dilon G. P., Yu X., Sridharan A., Ranieri J. P., Bellamkonda R. V. J. Biomater. Sci. Polym. Ed., 9, 1049-1069 (1998).
80. Unger E. C., Porter T., Culp W., Labell R., Matsunaga T., Zutshi R., Adv. Drug Del. Rev., 56, 291-1314 (2004).
81. Pislaru S. V., Pislaru C., Kinnick R. R., Eur. Heart J., 24, 1690-1698 (2003).
82. Malmsten M., "Surfactants and polymers in drug delivery," Marcel Dekker, New York, 2002.
83. Domb A. J., Lipospheres for the delivery of vaccines. U. S. Patent Application, 1990, allowed August (1992).
84. Domb A. J., Lipospheres for controlled delivery of substances. U. S. Patent 5188837, Feb (1993).
85. Domb A. J., Maniar M., Lipospheres for controlled delivery of Pharmaceuticals, pesticides and fertilizers. Nova Pharmaceutical Corp. 90-US6519[9107171], 79, 8-11 (1990).
86. Amselem S., Domb A. J., Alving C. R., Vaccine Res., 1, 383-395 (1992).
87. Morel S., Gasco M. R., Cavalli R., Int. J. Pharm., 119, 126 (1995).
88. Rasiel A., Sheskin T., Bergelson L., Domb A. J., Polymers for advanced technologies, 13, 127-136 (2002).
89. Khopade A. J., Jain N. K., Pharmazie, 52, 165-166 (1997).
90. Masters D. B., Domb A. J., Pharm. Res., 15, 1038-1045 (1998).
91. Domb A. J., J. Am. Mosq. Control Assoc., 11, 29-34 (1995).
92. Amselem S., Alving C. R., Domb A. J., Drugs Pharm. Sci., 77, 149-168 (1996).
93. Saraf S., Mishra D., Asthana A., Jain R., Singh S., Jain N. K., Vaccine, 24, 45-56 (2006).
94. Aquilano D., Cavalli R., Gasco M. R.,. Thermochimica acta, 230, 29-37 (1993).
95. Cortesi R., Esposito E., Luca G., Nastruzzi C., Biomaterials, 23, 2283-2294 (2002).
96. Lu D, Hickey A. J., AAPS PharmSciTech., 6, E641-E648 (2005).
97. Vyas S. P., Rawat M., Rawat A., Mahor S., Gupta P. N., Drug Dev. Ind. Pharm., 32, 699-707 (2006).
98. Garcia-Fuentes M., Torres D., Alonso M. J., Int. J. Pharm., 296, 122-132 (2005).
99. Yu L. X., Foster T. P., Sarver R. W., Moseley W. M., J. Pharm. Sci. 85, 396-401(1996).
100. Constantinides P. P., Scalart J. P., Lancastar S., Marcello J., Marks G., Ellens H., Smith P. L., Pharm. Res. 11, 1385-1390 (1994).
101. Bot A. I., Tarara T. E., Smith D. J., Bot S. R., Woods C. M., Weers J. G., Pharm. Res. 17, 275-283 (2000).
102. Bekeredjian R., Chen S., Grayburn P. A., Shohet R. V., Ultrasound in Med. Biol., 31, 687-691 (2005).
103. Bhat M., "Respiratory Drug Delivery 8," eds. by Dalby R., Byron P. R., Peart J., Farr S. J., Raleigh, NC: Davis Horwood International Publishing, 2002, pp. 427-429.
104. Bekerman T., Golenser J., Domb A., J. Pharm. Sci., 93, 1264-1270 (2004).